EcoDrugPlus

Glutamate Receptor, Ionotropic, Ampa 1a

Ensembl ID : ENSTNIG00000017056
Gene Symbol: GRIA1A
2 Cross references
251 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1b

Ensembl ID : ENSTNIG00000007666
Gene Symbol: GRIA1B
2 Cross references
249 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2b

Ensembl ID : ENSTNIG00000013036
Gene Symbol: GRIA2B
3 Cross references
223 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2b

Ensembl ID : ENSTNIG00000004419
Gene Symbol: GRIA2B
2 Cross references
202 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 3a

Ensembl ID : ENSTNIG00000011793
Gene Symbol: GRIA3A
2 Cross references
251 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSTNIG00000002369
Gene Symbol: GRIA4B
2 Cross references
248 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSTNIG00000004002
Gene Symbol: GRIN1A
2 Cross references
205 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSTNIG00000006276
Gene Symbol: GRIN2BB
2 Cross references
208 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSTNIG00000005693
Gene Symbol: GRIN2BB
2 Cross references
250 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSTNIG00000014741
Gene Symbol: GRM2B
2 Cross references
206 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSTNIG00000019202
Gene Symbol: GRM3
2 Cross references
215 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSTNIG00000009950
Gene Symbol: GRM5A
2 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).